DocGo DCGO Weighted Average Exercise Price of Vested and Expected to Vest Options

Weighted Average Exercise Price of Vested and Expected to Vest Options at other companies

Medline, Inc. MDLN

——

Other financials

Income statement

See full

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

See full

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

See full

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

See full

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

See full

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's weighted average exercise price of vested and expected to vest options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DocGo's weighted average exercise price of vested and expected to vest options?: DocGo (DCGO) reported weighted average exercise price of vested and expected to vest options of $6.89 in Q1 2026.
How has DocGo's weighted average exercise price of vested and expected to vest options changed year-over-year?: DocGo's weighted average exercise price of vested and expected to vest options decreased by 0.4% year-over-year, from $6.92 to $6.89.